The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.
Saved in:
| Title: | The discovery and optimization of pyrimidinone-containing MCH R1 antagonists. |
|---|---|
| Authors: | Hertzog DL; Metabolic and Viral Diseases Centre of Excellence for Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, NC 27707, USA. Donald.L.Hertzog@gsk.com, Al-Barazanji KA, Bigham EC, Bishop MJ, Britt CS, Carlton DL, Cooper JP, Daniels AJ, Garrido DM, Goetz AS, Grizzle MK, Guo YC, Handlon AL, Ignar DM, Morgan RO, Peat AJ, Tavares FX, Zhou H |
| Source: | Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2006 Sep 15; Vol. 16 (18), pp. 4723-7. Date of Electronic Publication: 2006 Jul 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0960-894X (Print) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 16870432 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The discovery and optimization of pyrimidinone-containing MCH R1 antagonists. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hertzog+DL%22">Hertzog DL</searchLink>; Metabolic and Viral Diseases Centre of Excellence for Drug Discovery, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, NC 27707, USA. Donald.L.Hertzog@gsk.com<br /><searchLink fieldCode="AU" term="%22Al-Barazanji+KA%22">Al-Barazanji KA</searchLink><br /><searchLink fieldCode="AU" term="%22Bigham+EC%22">Bigham EC</searchLink><br /><searchLink fieldCode="AU" term="%22Bishop+MJ%22">Bishop MJ</searchLink><br /><searchLink fieldCode="AU" term="%22Britt+CS%22">Britt CS</searchLink><br /><searchLink fieldCode="AU" term="%22Carlton+DL%22">Carlton DL</searchLink><br /><searchLink fieldCode="AU" term="%22Cooper+JP%22">Cooper JP</searchLink><br /><searchLink fieldCode="AU" term="%22Daniels+AJ%22">Daniels AJ</searchLink><br /><searchLink fieldCode="AU" term="%22Garrido+DM%22">Garrido DM</searchLink><br /><searchLink fieldCode="AU" term="%22Goetz+AS%22">Goetz AS</searchLink><br /><searchLink fieldCode="AU" term="%22Grizzle+MK%22">Grizzle MK</searchLink><br /><searchLink fieldCode="AU" term="%22Guo+YC%22">Guo YC</searchLink><br /><searchLink fieldCode="AU" term="%22Handlon+AL%22">Handlon AL</searchLink><br /><searchLink fieldCode="AU" term="%22Ignar+DM%22">Ignar DM</searchLink><br /><searchLink fieldCode="AU" term="%22Morgan+RO%22">Morgan RO</searchLink><br /><searchLink fieldCode="AU" term="%22Peat+AJ%22">Peat AJ</searchLink><br /><searchLink fieldCode="AU" term="%22Tavares+FX%22">Tavares FX</searchLink><br /><searchLink fieldCode="AU" term="%22Zhou+H%22">Zhou H</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229107377%22">Bioorganic & medicinal chemistry letters</searchLink> [Bioorg Med Chem Lett] 2006 Sep 15; Vol. 16 (18), pp. 4723-7. <i>Date of Electronic Publication: </i>2006 Jul 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9107377 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>0960-894X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220960894X%22">0960894X </searchLink><i>NLM ISO Abbreviation: </i>Bioorg Med Chem Lett <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=16870432 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.bmcl.2006.07.008 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4723 Titles: – TitleFull: The discovery and optimization of pyrimidinone-containing MCH R1 antagonists. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hertzog DL – PersonEntity: Name: NameFull: Al-Barazanji KA – PersonEntity: Name: NameFull: Bigham EC – PersonEntity: Name: NameFull: Bishop MJ – PersonEntity: Name: NameFull: Britt CS – PersonEntity: Name: NameFull: Carlton DL – PersonEntity: Name: NameFull: Cooper JP – PersonEntity: Name: NameFull: Daniels AJ – PersonEntity: Name: NameFull: Garrido DM – PersonEntity: Name: NameFull: Goetz AS – PersonEntity: Name: NameFull: Grizzle MK – PersonEntity: Name: NameFull: Guo YC – PersonEntity: Name: NameFull: Handlon AL – PersonEntity: Name: NameFull: Ignar DM – PersonEntity: Name: NameFull: Morgan RO – PersonEntity: Name: NameFull: Peat AJ – PersonEntity: Name: NameFull: Tavares FX – PersonEntity: Name: NameFull: Zhou H IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: 2006 Sep 15 Type: published Y: 2006 Identifiers: – Type: issn-print Value: 0960-894X Numbering: – Type: volume Value: 16 – Type: issue Value: 18 Titles: – TitleFull: Bioorganic & medicinal chemistry letters Type: main |
| ResultId | 1 |